NCT02700139.

Study name	Shamir aspheric ophthalmic lenses (MyLens) for myopic control clinical trial
Methods	Randomised parallel‐group design
Participants	Inclusion criteria: myopia between 0.75 ~ to 4.50 D and with‐the‐rule astigmatism not more than 1.50 D; difference between eyes, no more than 1.25 spherical equivalent; BCVA is equal to or better than 0.10 in logMAR scale (Snellen VA 6/7.5 or better); eyes straight at distance and near with best subjective correction; willing to be randomised and wear the study spectacles according to the instructions from practitioner; willing to come back for follow‐up; in the Optometry Clinic during the study period Exclusion criteria: abnormal ocular and general health; prior myopic treatment (e.g. refractive surgery and progressive lens wear for myopic control) before and during the study period; history of rigid contact lenses (including OK lenses) wearing; systemic condition which might affect refractive development (for example, Down's syndrome, Marfan's syndrome); ocular conditions which might affect the refractive error (for example, cataract, ptosis)
Interventions	Intervention: aspheric lens Comparison intervention: single vision spheric/toric lens
Outcomes	Primary outcome: AL Secondary outcomes: not reported Maximum follow‐up: 1 year
Starting date	January 2016
Contact information	clinicaltrials.gov/ct2/show/NCT02700139
Notes